Given the marked downregulation of NLGN3 following KPNB1 knockdown, and the previously reported roles of NLGN3 in various cancers, especially in nervous system tumors [36, 56–58], we hypothesized that KPNB1 regulated GBM progression through NLGN3. The gene discussed is NLGN3; the disease is nervous system neoplasm.